Ifm Investors Pty Ltd’s Abbott Laboratories Position
Does Ifm Investors Pty Ltd own Abbott Laboratories (ABT)? Yes — 379.1K shares worth $39M (+0.32% of its 13F portfolio) as of Q1 2026, up from 363.4K shares the prior filed quarter.
Position Value
$39M
Q1 2026
Shares
379.1K
% of Portfolio
+0.32%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 379.1K | $39M | +0.32% |
| Q4 2025 | 363.4K | $46M | +0.38% |
| Q3 2025 | 348.5K | $47M | +0.41% |
| Q2 2025 | 338.7K | $46M | +0.44% |
| Q1 2025 | 325.9K | $43M | +0.47% |
| Q3 2024 | 355.6K | $41M | +0.39% |
| Q2 2024 | 355.7K | $37M | +0.37% |
| Q1 2024 | 355.0K | $40M | +0.44% |
| Q4 2023 | 355.5K | $39M | +0.48% |
| Q3 2023 | 351.3K | $34M | +0.45% |
| Q2 2023 | 340.1K | $37M | +0.49% |
| Q1 2023 | 320.6K | $32M | +0.49% |
| Q4 2022 | 311.7K | $34M | +0.57% |
| Q3 2022 | 299.7K | $29M | +0.53% |
| Q2 2022 | 297.9K | $32M | +0.57% |
| Q1 2022 | 279.8K | $33M | +0.51% |
| Q4 2021 | 231.2K | $33M | +0.60% |
| Q3 2021 | 234.5K | $28M | +0.57% |
| Q2 2021 | 234.3K | $27M | +0.56% |
| Q1 2021 | 192.2K | $23M | +0.62% |
| Q4 2020 | 171.0K | $19M | +0.59% |
| Q3 2020 | 146.9K | $16M | +0.67% |
| Q2 2020 | 130.1K | $12M | +0.61% |
| Q1 2020 | 182.3K | $14M | +0.65% |
| Q4 2019 | 187.8K | $16M | +0.58% |
| Q3 2019 | 190.6K | $16M | +0.59% |
| Q2 2019 | 122.7K | $10M | +0.59% |
| Q1 2019 | 113.0K | $9M | +0.58% |
| Q4 2018 | 101.5K | $7M | +0.59% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ifm Investors Pty Ltd’s full portfolio or all institutional holders of ABT.